Literature DB >> 18190633

Chronic suprapubic catheterization in the management of patients with spinal cord injuries: analysis of upper and lower urinary tract complications.

Takayuki Sugimura1, Edwin Arnold, Sharon English, James Moore.   

Abstract

OBJECTIVE: To assess whether chronic suprapubic catheterization (SPC) in patients with spinal cord injury (SCI) is associated with a higher incidence of significant urinary tract complications than in patients whose urinary tracts are managed by other methods. PATIENTS AND METHODS: Our experience suggested that the incidence of complications in patients with SCI and SPC was acceptable and relatively low. Between 1988 and 2001, 1018 patients were admitted to our unit after SCI; 149 were managed by SPC and we retrospectively reviewed them, with a mean follow-up of 6 years. There were no complications in 49% of patients. Most complications were minor (urinary tract infection 27%, bladder stones 22%) and were easily managed. Only 20 patients had upper tract complications. Nine patients had renal scarring and 14, all quadriplegic, had upper tract calculi. One patient developed well-differentiated superficial transitional cell bladder cancer.
CONCLUSIONS: Patients with SCI often prefer SPC than other methods offered to them, because of quality-of-life issues. The incidence of significant complications might not be as high as previously reported, and with a commitment to careful follow-up, SPC can be a safe option for carefully selected patients if adequate surveillance can be ensured.

Entities:  

Mesh:

Year:  2008        PMID: 18190633     DOI: 10.1111/j.1464-410X.2007.07404.x

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  16 in total

1.  To clamp or not to clamp? Bladder management by suprapubic catheterization in patients with neurogenic bladder dysfunction.

Authors:  Jürgen Pannek; Konrad Göcking; Ulf Bersch
Journal:  World J Urol       Date:  2010-01-05       Impact factor: 4.226

2.  Structural brain changes versus self-report: machine-learning classification of chronic fatigue syndrome patients.

Authors:  Landrew S Sevel; Jeff Boissoneault; Janelle E Letzen; Michael E Robinson; Roland Staud
Journal:  Exp Brain Res       Date:  2018-05-30       Impact factor: 1.972

3.  Spinal Cord Injury Creates Unique Challenges in Diagnosis and Management of Catheter-Associated Urinary Tract Infection.

Authors:  Felicia Skelton-Dudley; James Doan; Katie Suda; S Ann Holmes; Charlesnika Evans; Barbara Trautner
Journal:  Top Spinal Cord Inj Rehabil       Date:  2019

Review 4.  Neurogenic bladder: from diagnosis to management.

Authors:  Ellen Goldmark; Benjamin Niver; David A Ginsberg
Journal:  Curr Urol Rep       Date:  2014-10       Impact factor: 3.092

Review 5.  Non-surgical urologic management of neurogenic bladder after spinal cord injury.

Authors:  Paholo G Barboglio Romo; Christopher P Smith; Ashley Cox; Márcio A Averbeck; Caroline Dowling; Cleveland Beckford; Paul Manohar; Sergio Duran; Anne P Cameron
Journal:  World J Urol       Date:  2018-07-26       Impact factor: 4.226

6.  Urinary tract infections in patients with spinal cord injuries.

Authors:  Frederiek D'Hondt; Karel Everaert
Journal:  Curr Infect Dis Rep       Date:  2011-12       Impact factor: 3.725

7.  Ceftriaxone treatment of complicated urinary tract infections as a risk factor for enterococcal re-infection and prolonged hospitalization: A 6-year retrospective study.

Authors:  Kristian Karlović; Jadranka Nikolić; Jurica Arapović
Journal:  Bosn J Basic Med Sci       Date:  2018-11-07       Impact factor: 3.363

Review 8.  Medical Management of Neurogenic Bladder for Children and Adults: A Review.

Authors:  Elizabeth Lucas
Journal:  Top Spinal Cord Inj Rehabil       Date:  2019

9.  Managing the urinary tract in spinal cord injury.

Authors:  Simon C W Harrison
Journal:  Indian J Urol       Date:  2010-04

10.  Muscle invasive bladder cancer presenting as recurrent autonomic dysreflexia - a wolf in wolf's clothing.

Authors:  Ryan Fitzpatrick; Richard Baverstock
Journal:  J Spinal Cord Med       Date:  2018-06-20       Impact factor: 1.985

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.